Contribution of the multidrug efflux transporter CmeABC to antibiotic resistance in different campylobacter species

Foodborne Pathogens and Disease

Volumn 7, Issue 1, 2010, Pages 77-83

  Guo, Baoqing ^a   Lin, Jun ^a,b   Reynolds, Donald L ^a   Zhang, Qijing ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CARRIER PROTEIN; CEFALOTIN; CEFOPERAZONE; CEFOTAXIME; CHOLIC ACID; CIPROFLOXACIN; DODECYL SULFATE SODIUM; ERYTHROMYCIN; ETHIDIUM BROMIDE; GENTAMICIN; POLYMYXIN B; PROTEIN CMEABC; RIFAMPICIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER COLI; CAMPYLOBACTER FETUS; CAMPYLOBACTER JEJUNI; CAMPYLOBACTER LARI; CAMPYLOBACTER UPSALIENSIS; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; ORTHOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL;

BACTERIAL PROTEINS; CAMPYLOBACTER; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, MDR; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, INSERTIONAL; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY;

CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER FETUS; CAMPYLOBACTER JEJUNI; CAMPYLOBACTER LARI; CAMPYLOBACTER UPSALIENSIS;

EID: 74549186463     PISSN: 15353141     EISSN: None     Source Type: Journal    
DOI: 10.1089/fpd.2009.0354     Document Type: Article

References (31)

1. Akiba M, Lin J, Barton YW, and Zhang Q. Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother 2006;57:52-60.
2. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001;32:1201-1206.
3. Bourke B, Chan VL, and Sherman P. Campylobacter upsaliensis: waiting in the wings. Clin Microbiol Rev 1998;11:440-449.
4. Burnens AP and Nicolet J. Detection of Campylobacter upsaliensis in diarrheic dogs and cats, using a selective medium with cefoperazone. Am J Vet Res 1992;53:48-51.
5. Cagliero C, Cloix L, Cloeckaert A, and Payot S. High genetic variation in the multidrug transporter cmeB gene in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 2006;58:168-172.
6. Cagliero C, Mouline C, Payot S, and Cloeckaert A. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli. J Antimicrob Chemother 2005;56:948-950. (Pubitemid 41631924)
7. Corcoran D, Quinn T, Cotter L, O'Halloran F, and Fanning S. Characterization of a cmeABC operon in a quinolone-resistant Campylobacter coli isolate of Irish origin. Microb Drug Resist 2005;11:303-308.
8. Fakhr MK and Logue CM. Sequence variation in the outer membrane protein-encoding gene cmeC, conferring multidrug resistance among Campylobacter jejuni and Campylobacter coli strains isolated from different hosts. J Clin Microbiol 2007;45: 3381-3383.
9. Fouts DE, Mongodin EF, Mandrell RE, Miller WG, Rasko DA, Ravel J, Brinkac LM, DeBoy RT, Parker CT, Daugherty SC, Dodson RJ, Durkin AS, Madupu R, Sullivan SA, Shetty JU, Ayodeji MA, Shvartsbeyn A, Schatz MC, Badger JH, Fraser CM, and Nelson KE. Major structural differences and novel potential virulence mechanisms from the genomes of multiple Campylobacter species. PLoS Biol 2005;3:e15.
10. Goossens H, De Boeck M, Coignau H, Vlaes L, Van den Borre C, and Butzler JP. Modified selective medium for isolation of Campylobacter spp. from feces: comparison with Preston medium, a blood-free medium, and a filtration system. J Clin Microbiol 1986;24:840-843.
11. Guerry P, Yao R, Alm RA, Burr DH, and Trust TJ. Systems of experimental genetics for Campylobacter species. Methods Enzymol 1994;235:474-481.
12. Guillaume G, Ledent V, Moens W, and Collard JM. Phylogeny of efflux-mediated tetracycline resistance genes and related proteins revisited. Microb Drug Resist 2004;10:11-26.
13. Karmali MA, De Grandis S, and Fleming PC. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother 1981;19:593-597.
14. Lachance N, Gaudreau C, Lamothe F, and Lariviere LA. Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother 1991;35: 813-818.
15. Lastovica AJ and Allos BM. Clinical significance of Campylobacter and related species other than Campylobacter jejuni and Campylobacter coli. In: Campylobacter, 3rd edition. Nachamkin I, Szymanski CM, and Blaser MJ (eds.). Washington, DC: ASM Press, 2008, pp. 123-149.
16. Lastovica AJ and Le Roux E. Efficient isolation of Campylobacter upsaliensis from stools. J Clin Microbiol 2001;39:4222-4223.
17. Lin J, Akiba M, Sahin O, and Zhang Q. CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob Agents Chemother 2005a;49:1067-1075. (Pubitemid 40327725)
18. Lin J, Cagliero C, Guo B, Barton YW, Maurel MC, Payot S, and Zhang Q. Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni. J Bacteriol 2005b;187:7417-7424. (Pubitemid 41507798)
19. Lin J, Michel LO, and Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother 2002;46:2124-2131.
20. Lin J, Sahin O, Michel LO, and Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 2003;71: 4250-4259.
21. Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, and Zhang Q. Antibiotic resistance in Campylobacter: emergence, transmission, and persistence. Future Microbiol 2009;4:189-200.
22. Luo N, Sahin O, Lin J, Michel LO, and Zhang Q. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother 2003;47:390-394.
23. Mamelli L, Prouzet-Mauleon V, Pages JM, Megraud F, and Bolla JM. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother 2005;56:491-497.
24. Martinot M, Jaulhac B, Moog R, De Martino S, Kehrli P, Monteil H, and Piemont Y. Campylobacter lari bacteremia. Clin Microbiol Infect 2001;7:96-97.
25. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995;8: 496-514.
26. Ng LK, Taylor DE, and Stiles ME. Characterization of freshly isolated Campylobacter coli strains and suitability of selective media for their growth. J Clin Microbiol 1988;26:518-523.
27. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006;19:382-402.
28. Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005;56:20-51.
29. Pumbwe L and Piddock LJ. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett 2002;206:185-189.
30. Tee W and Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis 1998;26:91-96.
31. Vandamme P. Taxonomy of the family Campylobacteraceae. In: Campylobacter, 2nd edition. Nachamkin I and Blaser MJ (eds.). Washington, DC: ASM Press, 2000, pp. 3-26.